Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program
by Frost, Nikolaj (Author)
, Christopoulos, Petros (Author)
, Kauffmann-Guerrero, Diego (Author)
, Stratmann, Jan (Author)
, Riedel, Richard (Author)
, Schaefer, Monica (Author)
, Alt, Jürgen (Author)
, Gütz, Sylvia (Author)
, Christoph, Daniel C. (Author)
, Laack, Eckart (Author)
, Faehling, Martin (Author)
, Fischer, Richard (Author)
, Fenchel, Klaus (Author)
, Haen, Sebastian P. (Author)
, Heukamp, Lukas (Author)
, Schulz, Christian (Author)
, Griesinger, Frank (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource